SCHEMBL6709945

SCHEMBL6709945

O=C(Nc1ccc(Cl)cc1-c1nnn[nH]1)c1noc2ccc(-c3ccccc3C(F)(F)F)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 3/20 0.40
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 2/20 0.38
KMT2A Q03164 2/20 0.38
TSHR P16473 1/20 0.38
EPHX2 P34913 1/20 0.37
MAPT P10636 2/20 0.36
MEN1 O00255 1/20 0.36
XBP1 P17861 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KDM4E B2RXH2 1/20 0.36
TP53 P04637 2/20 0.35
ROCK1 Q13464 1/20 0.35
GRM5 P41594 1/20 0.35
HTT P42858 1/20 0.35
F10 P00742 1/20 0.35
KIT P10721 1/20 0.34
KDR P35968 1/20 0.34
FLT3 P36888 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710221 0.94 EPHX2 (0.43) HIF1ARAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL6711582 0.91 KMT2A (0.36) HIF1ARAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL6709177 0.90 HIF1A (0.42) HIF1ASMN1; SMN2TP53ROCK1F10
SCHEMBL6710378 0.88 SMN1; SMN2 (0.35) HIF1ARAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL6707935 0.88 HIF1A (0.45) HIF1ASMN1; SMN2NPC1KMT2AMAPT
SCHEMBL6711801 0.86 HIF1A (0.43) HIF1ARAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL6709169 0.84 EPHX2 (0.41) HIF1ARAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL6710375 0.84 HIF1A (0.57) HIF1AROCK1
SCHEMBL6710332 0.82 EPHX2 (0.39) HIF1ARAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL6708718 0.81 HIF1A (0.42) HIF1ARAB9ASMN1; SMN2NPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 HIF1A 296/4885RAB9A 3732/4885SMN1; SMN2 2635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.